Global TB Vaccines Market Growth 2025-2031
The global TB Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Guerin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?TB Vaccines Industry Forecast? looks at past sales and reviews total world TB Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected TB Vaccines sales for 2025 through 2031. With TB Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TB Vaccines industry.
This Insight Report provides a comprehensive analysis of the global TB Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TB Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global TB Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TB Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TB Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of TB Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global TB Vaccines market?
What factors are driving TB Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do TB Vaccines market opportunities vary by end market size?
How does TB Vaccines break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Guerin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?TB Vaccines Industry Forecast? looks at past sales and reviews total world TB Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected TB Vaccines sales for 2025 through 2031. With TB Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TB Vaccines industry.
This Insight Report provides a comprehensive analysis of the global TB Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TB Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global TB Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TB Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TB Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of TB Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Immunotherapeutic Vaccines
- Booster Vaccines
- Others
- Hospitals
- Private Clinics
- Research Institutes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck & Co.,Inc
- Sanofi Pasteur
- Japan BCG Laboratory
- China National Biotec Group
- Serum Institute
- India Pvt. Ltd
- InterVax Ltd
- GreenSignal
- Bio Pharma Limited
- Statens Serum Institut
What is the 10-year outlook for the global TB Vaccines market?
What factors are driving TB Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do TB Vaccines market opportunities vary by end market size?
How does TB Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global TB Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for TB Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for TB Vaccines by Country/Region, 2020, 2024 & 2031
2.2 TB Vaccines Segment by Type
2.2.1 Immunotherapeutic Vaccines
2.2.2 Booster Vaccines
2.2.3 Others
2.3 TB Vaccines Sales by Type
2.3.1 Global TB Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global TB Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global TB Vaccines Sale Price by Type (2020-2025)
2.4 TB Vaccines Segment by Application
2.4.1 Hospitals
2.4.2 Private Clinics
2.4.3 Research Institutes
2.5 TB Vaccines Sales by Application
2.5.1 Global TB Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global TB Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global TB Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global TB Vaccines Breakdown Data by Company
3.1.1 Global TB Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global TB Vaccines Sales Market Share by Company (2020-2025)
3.2 Global TB Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global TB Vaccines Revenue by Company (2020-2025)
3.2.2 Global TB Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global TB Vaccines Sale Price by Company
3.4 Key Manufacturers TB Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers TB Vaccines Product Location Distribution
3.4.2 Players TB Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TB VACCINES BY GEOGRAPHIC REGION
4.1 World Historic TB Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global TB Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global TB Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic TB Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global TB Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global TB Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas TB Vaccines Sales Growth
4.4 APAC TB Vaccines Sales Growth
4.5 Europe TB Vaccines Sales Growth
4.6 Middle East & Africa TB Vaccines Sales Growth
5 AMERICAS
5.1 Americas TB Vaccines Sales by Country
5.1.1 Americas TB Vaccines Sales by Country (2020-2025)
5.1.2 Americas TB Vaccines Revenue by Country (2020-2025)
5.2 Americas TB Vaccines Sales by Type (2020-2025)
5.3 Americas TB Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TB Vaccines Sales by Region
6.1.1 APAC TB Vaccines Sales by Region (2020-2025)
6.1.2 APAC TB Vaccines Revenue by Region (2020-2025)
6.2 APAC TB Vaccines Sales by Type (2020-2025)
6.3 APAC TB Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe TB Vaccines by Country
7.1.1 Europe TB Vaccines Sales by Country (2020-2025)
7.1.2 Europe TB Vaccines Revenue by Country (2020-2025)
7.2 Europe TB Vaccines Sales by Type (2020-2025)
7.3 Europe TB Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa TB Vaccines by Country
8.1.1 Middle East & Africa TB Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa TB Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa TB Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa TB Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of TB Vaccines
10.3 Manufacturing Process Analysis of TB Vaccines
10.4 Industry Chain Structure of TB Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 TB Vaccines Distributors
11.3 TB Vaccines Customer
12 WORLD FORECAST REVIEW FOR TB VACCINES BY GEOGRAPHIC REGION
12.1 Global TB Vaccines Market Size Forecast by Region
12.1.1 Global TB Vaccines Forecast by Region (2026-2031)
12.1.2 Global TB Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global TB Vaccines Forecast by Type (2026-2031)
12.7 Global TB Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck & Co.,Inc
13.1.1 Merck & Co.,Inc Company Information
13.1.2 Merck & Co.,Inc TB Vaccines Product Portfolios and Specifications
13.1.3 Merck & Co.,Inc TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck & Co.,Inc Main Business Overview
13.1.5 Merck & Co.,Inc Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur TB Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Pasteur TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Japan BCG Laboratory
13.3.1 Japan BCG Laboratory Company Information
13.3.2 Japan BCG Laboratory TB Vaccines Product Portfolios and Specifications
13.3.3 Japan BCG Laboratory TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Japan BCG Laboratory Main Business Overview
13.3.5 Japan BCG Laboratory Latest Developments
13.4 China National Biotec Group
13.4.1 China National Biotec Group Company Information
13.4.2 China National Biotec Group TB Vaccines Product Portfolios and Specifications
13.4.3 China National Biotec Group TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 China National Biotec Group Main Business Overview
13.4.5 China National Biotec Group Latest Developments
13.5 Serum Institute
13.5.1 Serum Institute Company Information
13.5.2 Serum Institute TB Vaccines Product Portfolios and Specifications
13.5.3 Serum Institute TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Serum Institute Main Business Overview
13.5.5 Serum Institute Latest Developments
13.6 India Pvt. Ltd
13.6.1 India Pvt. Ltd Company Information
13.6.2 India Pvt. Ltd TB Vaccines Product Portfolios and Specifications
13.6.3 India Pvt. Ltd TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 India Pvt. Ltd Main Business Overview
13.6.5 India Pvt. Ltd Latest Developments
13.7 InterVax Ltd
13.7.1 InterVax Ltd Company Information
13.7.2 InterVax Ltd TB Vaccines Product Portfolios and Specifications
13.7.3 InterVax Ltd TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 InterVax Ltd Main Business Overview
13.7.5 InterVax Ltd Latest Developments
13.8 GreenSignal
13.8.1 GreenSignal Company Information
13.8.2 GreenSignal TB Vaccines Product Portfolios and Specifications
13.8.3 GreenSignal TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 GreenSignal Main Business Overview
13.8.5 GreenSignal Latest Developments
13.9 Bio Pharma Limited
13.9.1 Bio Pharma Limited Company Information
13.9.2 Bio Pharma Limited TB Vaccines Product Portfolios and Specifications
13.9.3 Bio Pharma Limited TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Bio Pharma Limited Main Business Overview
13.9.5 Bio Pharma Limited Latest Developments
13.10 Statens Serum Institut
13.10.1 Statens Serum Institut Company Information
13.10.2 Statens Serum Institut TB Vaccines Product Portfolios and Specifications
13.10.3 Statens Serum Institut TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Statens Serum Institut Main Business Overview
13.10.5 Statens Serum Institut Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global TB Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for TB Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for TB Vaccines by Country/Region, 2020, 2024 & 2031
2.2 TB Vaccines Segment by Type
2.2.1 Immunotherapeutic Vaccines
2.2.2 Booster Vaccines
2.2.3 Others
2.3 TB Vaccines Sales by Type
2.3.1 Global TB Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global TB Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global TB Vaccines Sale Price by Type (2020-2025)
2.4 TB Vaccines Segment by Application
2.4.1 Hospitals
2.4.2 Private Clinics
2.4.3 Research Institutes
2.5 TB Vaccines Sales by Application
2.5.1 Global TB Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global TB Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global TB Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global TB Vaccines Breakdown Data by Company
3.1.1 Global TB Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global TB Vaccines Sales Market Share by Company (2020-2025)
3.2 Global TB Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global TB Vaccines Revenue by Company (2020-2025)
3.2.2 Global TB Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global TB Vaccines Sale Price by Company
3.4 Key Manufacturers TB Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers TB Vaccines Product Location Distribution
3.4.2 Players TB Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TB VACCINES BY GEOGRAPHIC REGION
4.1 World Historic TB Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global TB Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global TB Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic TB Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global TB Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global TB Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas TB Vaccines Sales Growth
4.4 APAC TB Vaccines Sales Growth
4.5 Europe TB Vaccines Sales Growth
4.6 Middle East & Africa TB Vaccines Sales Growth
5 AMERICAS
5.1 Americas TB Vaccines Sales by Country
5.1.1 Americas TB Vaccines Sales by Country (2020-2025)
5.1.2 Americas TB Vaccines Revenue by Country (2020-2025)
5.2 Americas TB Vaccines Sales by Type (2020-2025)
5.3 Americas TB Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TB Vaccines Sales by Region
6.1.1 APAC TB Vaccines Sales by Region (2020-2025)
6.1.2 APAC TB Vaccines Revenue by Region (2020-2025)
6.2 APAC TB Vaccines Sales by Type (2020-2025)
6.3 APAC TB Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe TB Vaccines by Country
7.1.1 Europe TB Vaccines Sales by Country (2020-2025)
7.1.2 Europe TB Vaccines Revenue by Country (2020-2025)
7.2 Europe TB Vaccines Sales by Type (2020-2025)
7.3 Europe TB Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa TB Vaccines by Country
8.1.1 Middle East & Africa TB Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa TB Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa TB Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa TB Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of TB Vaccines
10.3 Manufacturing Process Analysis of TB Vaccines
10.4 Industry Chain Structure of TB Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 TB Vaccines Distributors
11.3 TB Vaccines Customer
12 WORLD FORECAST REVIEW FOR TB VACCINES BY GEOGRAPHIC REGION
12.1 Global TB Vaccines Market Size Forecast by Region
12.1.1 Global TB Vaccines Forecast by Region (2026-2031)
12.1.2 Global TB Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global TB Vaccines Forecast by Type (2026-2031)
12.7 Global TB Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck & Co.,Inc
13.1.1 Merck & Co.,Inc Company Information
13.1.2 Merck & Co.,Inc TB Vaccines Product Portfolios and Specifications
13.1.3 Merck & Co.,Inc TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck & Co.,Inc Main Business Overview
13.1.5 Merck & Co.,Inc Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur TB Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Pasteur TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Japan BCG Laboratory
13.3.1 Japan BCG Laboratory Company Information
13.3.2 Japan BCG Laboratory TB Vaccines Product Portfolios and Specifications
13.3.3 Japan BCG Laboratory TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Japan BCG Laboratory Main Business Overview
13.3.5 Japan BCG Laboratory Latest Developments
13.4 China National Biotec Group
13.4.1 China National Biotec Group Company Information
13.4.2 China National Biotec Group TB Vaccines Product Portfolios and Specifications
13.4.3 China National Biotec Group TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 China National Biotec Group Main Business Overview
13.4.5 China National Biotec Group Latest Developments
13.5 Serum Institute
13.5.1 Serum Institute Company Information
13.5.2 Serum Institute TB Vaccines Product Portfolios and Specifications
13.5.3 Serum Institute TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Serum Institute Main Business Overview
13.5.5 Serum Institute Latest Developments
13.6 India Pvt. Ltd
13.6.1 India Pvt. Ltd Company Information
13.6.2 India Pvt. Ltd TB Vaccines Product Portfolios and Specifications
13.6.3 India Pvt. Ltd TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 India Pvt. Ltd Main Business Overview
13.6.5 India Pvt. Ltd Latest Developments
13.7 InterVax Ltd
13.7.1 InterVax Ltd Company Information
13.7.2 InterVax Ltd TB Vaccines Product Portfolios and Specifications
13.7.3 InterVax Ltd TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 InterVax Ltd Main Business Overview
13.7.5 InterVax Ltd Latest Developments
13.8 GreenSignal
13.8.1 GreenSignal Company Information
13.8.2 GreenSignal TB Vaccines Product Portfolios and Specifications
13.8.3 GreenSignal TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 GreenSignal Main Business Overview
13.8.5 GreenSignal Latest Developments
13.9 Bio Pharma Limited
13.9.1 Bio Pharma Limited Company Information
13.9.2 Bio Pharma Limited TB Vaccines Product Portfolios and Specifications
13.9.3 Bio Pharma Limited TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Bio Pharma Limited Main Business Overview
13.9.5 Bio Pharma Limited Latest Developments
13.10 Statens Serum Institut
13.10.1 Statens Serum Institut Company Information
13.10.2 Statens Serum Institut TB Vaccines Product Portfolios and Specifications
13.10.3 Statens Serum Institut TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Statens Serum Institut Main Business Overview
13.10.5 Statens Serum Institut Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. TB Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. TB Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immunotherapeutic Vaccines
Table 4. Major Players of Booster Vaccines
Table 5. Major Players of Others
Table 6. Global TB Vaccines Sales by Type (2020-2025) & (K Units)
Table 7. Global TB Vaccines Sales Market Share by Type (2020-2025)
Table 8. Global TB Vaccines Revenue by Type (2020-2025) & ($ million)
Table 9. Global TB Vaccines Revenue Market Share by Type (2020-2025)
Table 10. Global TB Vaccines Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global TB Vaccines Sale by Application (2020-2025) & (K Units)
Table 12. Global TB Vaccines Sale Market Share by Application (2020-2025)
Table 13. Global TB Vaccines Revenue by Application (2020-2025) & ($ million)
Table 14. Global TB Vaccines Revenue Market Share by Application (2020-2025)
Table 15. Global TB Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global TB Vaccines Sales by Company (2020-2025) & (K Units)
Table 17. Global TB Vaccines Sales Market Share by Company (2020-2025)
Table 18. Global TB Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 19. Global TB Vaccines Revenue Market Share by Company (2020-2025)
Table 20. Global TB Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers TB Vaccines Producing Area Distribution and Sales Area
Table 22. Players TB Vaccines Products Offered
Table 23. TB Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global TB Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global TB Vaccines Sales Market Share Geographic Region (2020-2025)
Table 28. Global TB Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global TB Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global TB Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global TB Vaccines Sales Market Share by Country/Region (2020-2025)
Table 32. Global TB Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global TB Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas TB Vaccines Sales by Country (2020-2025) & (K Units)
Table 35. Americas TB Vaccines Sales Market Share by Country (2020-2025)
Table 36. Americas TB Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas TB Vaccines Sales by Type (2020-2025) & (K Units)
Table 38. Americas TB Vaccines Sales by Application (2020-2025) & (K Units)
Table 39. APAC TB Vaccines Sales by Region (2020-2025) & (K Units)
Table 40. APAC TB Vaccines Sales Market Share by Region (2020-2025)
Table 41. APAC TB Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC TB Vaccines Sales by Type (2020-2025) & (K Units)
Table 43. APAC TB Vaccines Sales by Application (2020-2025) & (K Units)
Table 44. Europe TB Vaccines Sales by Country (2020-2025) & (K Units)
Table 45. Europe TB Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe TB Vaccines Sales by Type (2020-2025) & (K Units)
Table 47. Europe TB Vaccines Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa TB Vaccines Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa TB Vaccines Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa TB Vaccines Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa TB Vaccines Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of TB Vaccines
Table 53. Key Market Challenges & Risks of TB Vaccines
Table 54. Key Industry Trends of TB Vaccines
Table 55. TB Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. TB Vaccines Distributors List
Table 58. TB Vaccines Customer List
Table 59. Global TB Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global TB Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas TB Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas TB Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC TB Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC TB Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe TB Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe TB Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa TB Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa TB Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global TB Vaccines Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global TB Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global TB Vaccines Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global TB Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Merck & Co.,Inc Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck & Co.,Inc TB Vaccines Product Portfolios and Specifications
Table 75. Merck & Co.,Inc TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Merck & Co.,Inc Main Business
Table 77. Merck & Co.,Inc Latest Developments
Table 78. Sanofi Pasteur Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Pasteur TB Vaccines Product Portfolios and Specifications
Table 80. Sanofi Pasteur TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Sanofi Pasteur Main Business
Table 82. Sanofi Pasteur Latest Developments
Table 83. Japan BCG Laboratory Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Japan BCG Laboratory TB Vaccines Product Portfolios and Specifications
Table 85. Japan BCG Laboratory TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan BCG Laboratory Main Business
Table 87. Japan BCG Laboratory Latest Developments
Table 88. China National Biotec Group Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. China National Biotec Group TB Vaccines Product Portfolios and Specifications
Table 90. China National Biotec Group TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. China National Biotec Group Main Business
Table 92. China National Biotec Group Latest Developments
Table 93. Serum Institute Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Serum Institute TB Vaccines Product Portfolios and Specifications
Table 95. Serum Institute TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Serum Institute Main Business
Table 97. Serum Institute Latest Developments
Table 98. India Pvt. Ltd Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. India Pvt. Ltd TB Vaccines Product Portfolios and Specifications
Table 100. India Pvt. Ltd TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. India Pvt. Ltd Main Business
Table 102. India Pvt. Ltd Latest Developments
Table 103. InterVax Ltd Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. InterVax Ltd TB Vaccines Product Portfolios and Specifications
Table 105. InterVax Ltd TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. InterVax Ltd Main Business
Table 107. InterVax Ltd Latest Developments
Table 108. GreenSignal Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. GreenSignal TB Vaccines Product Portfolios and Specifications
Table 110. GreenSignal TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. GreenSignal Main Business
Table 112. GreenSignal Latest Developments
Table 113. Bio Pharma Limited Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio Pharma Limited TB Vaccines Product Portfolios and Specifications
Table 115. Bio Pharma Limited TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Bio Pharma Limited Main Business
Table 117. Bio Pharma Limited Latest Developments
Table 118. Statens Serum Institut Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Statens Serum Institut TB Vaccines Product Portfolios and Specifications
Table 120. Statens Serum Institut TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Statens Serum Institut Main Business
Table 122. Statens Serum Institut Latest Developments
Table 1. TB Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. TB Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immunotherapeutic Vaccines
Table 4. Major Players of Booster Vaccines
Table 5. Major Players of Others
Table 6. Global TB Vaccines Sales by Type (2020-2025) & (K Units)
Table 7. Global TB Vaccines Sales Market Share by Type (2020-2025)
Table 8. Global TB Vaccines Revenue by Type (2020-2025) & ($ million)
Table 9. Global TB Vaccines Revenue Market Share by Type (2020-2025)
Table 10. Global TB Vaccines Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global TB Vaccines Sale by Application (2020-2025) & (K Units)
Table 12. Global TB Vaccines Sale Market Share by Application (2020-2025)
Table 13. Global TB Vaccines Revenue by Application (2020-2025) & ($ million)
Table 14. Global TB Vaccines Revenue Market Share by Application (2020-2025)
Table 15. Global TB Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global TB Vaccines Sales by Company (2020-2025) & (K Units)
Table 17. Global TB Vaccines Sales Market Share by Company (2020-2025)
Table 18. Global TB Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 19. Global TB Vaccines Revenue Market Share by Company (2020-2025)
Table 20. Global TB Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers TB Vaccines Producing Area Distribution and Sales Area
Table 22. Players TB Vaccines Products Offered
Table 23. TB Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global TB Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global TB Vaccines Sales Market Share Geographic Region (2020-2025)
Table 28. Global TB Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global TB Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global TB Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global TB Vaccines Sales Market Share by Country/Region (2020-2025)
Table 32. Global TB Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global TB Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas TB Vaccines Sales by Country (2020-2025) & (K Units)
Table 35. Americas TB Vaccines Sales Market Share by Country (2020-2025)
Table 36. Americas TB Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas TB Vaccines Sales by Type (2020-2025) & (K Units)
Table 38. Americas TB Vaccines Sales by Application (2020-2025) & (K Units)
Table 39. APAC TB Vaccines Sales by Region (2020-2025) & (K Units)
Table 40. APAC TB Vaccines Sales Market Share by Region (2020-2025)
Table 41. APAC TB Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC TB Vaccines Sales by Type (2020-2025) & (K Units)
Table 43. APAC TB Vaccines Sales by Application (2020-2025) & (K Units)
Table 44. Europe TB Vaccines Sales by Country (2020-2025) & (K Units)
Table 45. Europe TB Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe TB Vaccines Sales by Type (2020-2025) & (K Units)
Table 47. Europe TB Vaccines Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa TB Vaccines Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa TB Vaccines Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa TB Vaccines Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa TB Vaccines Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of TB Vaccines
Table 53. Key Market Challenges & Risks of TB Vaccines
Table 54. Key Industry Trends of TB Vaccines
Table 55. TB Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. TB Vaccines Distributors List
Table 58. TB Vaccines Customer List
Table 59. Global TB Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global TB Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas TB Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas TB Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC TB Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC TB Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe TB Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe TB Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa TB Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa TB Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global TB Vaccines Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global TB Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global TB Vaccines Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global TB Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Merck & Co.,Inc Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck & Co.,Inc TB Vaccines Product Portfolios and Specifications
Table 75. Merck & Co.,Inc TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Merck & Co.,Inc Main Business
Table 77. Merck & Co.,Inc Latest Developments
Table 78. Sanofi Pasteur Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Pasteur TB Vaccines Product Portfolios and Specifications
Table 80. Sanofi Pasteur TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Sanofi Pasteur Main Business
Table 82. Sanofi Pasteur Latest Developments
Table 83. Japan BCG Laboratory Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Japan BCG Laboratory TB Vaccines Product Portfolios and Specifications
Table 85. Japan BCG Laboratory TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan BCG Laboratory Main Business
Table 87. Japan BCG Laboratory Latest Developments
Table 88. China National Biotec Group Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. China National Biotec Group TB Vaccines Product Portfolios and Specifications
Table 90. China National Biotec Group TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. China National Biotec Group Main Business
Table 92. China National Biotec Group Latest Developments
Table 93. Serum Institute Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Serum Institute TB Vaccines Product Portfolios and Specifications
Table 95. Serum Institute TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Serum Institute Main Business
Table 97. Serum Institute Latest Developments
Table 98. India Pvt. Ltd Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. India Pvt. Ltd TB Vaccines Product Portfolios and Specifications
Table 100. India Pvt. Ltd TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. India Pvt. Ltd Main Business
Table 102. India Pvt. Ltd Latest Developments
Table 103. InterVax Ltd Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. InterVax Ltd TB Vaccines Product Portfolios and Specifications
Table 105. InterVax Ltd TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. InterVax Ltd Main Business
Table 107. InterVax Ltd Latest Developments
Table 108. GreenSignal Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. GreenSignal TB Vaccines Product Portfolios and Specifications
Table 110. GreenSignal TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. GreenSignal Main Business
Table 112. GreenSignal Latest Developments
Table 113. Bio Pharma Limited Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio Pharma Limited TB Vaccines Product Portfolios and Specifications
Table 115. Bio Pharma Limited TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Bio Pharma Limited Main Business
Table 117. Bio Pharma Limited Latest Developments
Table 118. Statens Serum Institut Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Statens Serum Institut TB Vaccines Product Portfolios and Specifications
Table 120. Statens Serum Institut TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Statens Serum Institut Main Business
Table 122. Statens Serum Institut Latest Developments
LIST OF FIGURES
Figure 1. Picture of TB Vaccines
Figure 2. TB Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global TB Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global TB Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. TB Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. TB Vaccines Sales Market Share by Country/Region (2024)
Figure 10. TB Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Immunotherapeutic Vaccines
Figure 12. Product Picture of Booster Vaccines
Figure 13. Product Picture of Others
Figure 14. Global TB Vaccines Sales Market Share by Type in 2025
Figure 15. Global TB Vaccines Revenue Market Share by Type (2020-2025)
Figure 16. TB Vaccines Consumed in Hospitals
Figure 17. Global TB Vaccines Market: Hospitals (2020-2025) & (K Units)
Figure 18. TB Vaccines Consumed in Private Clinics
Figure 19. Global TB Vaccines Market: Private Clinics (2020-2025) & (K Units)
Figure 20. TB Vaccines Consumed in Research Institutes
Figure 21. Global TB Vaccines Market: Research Institutes (2020-2025) & (K Units)
Figure 22. Global TB Vaccines Sale Market Share by Application (2024)
Figure 23. Global TB Vaccines Revenue Market Share by Application in 2025
Figure 24. TB Vaccines Sales by Company in 2025 (K Units)
Figure 25. Global TB Vaccines Sales Market Share by Company in 2025
Figure 26. TB Vaccines Revenue by Company in 2025 ($ millions)
Figure 27. Global TB Vaccines Revenue Market Share by Company in 2025
Figure 28. Global TB Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global TB Vaccines Revenue Market Share by Geographic Region in 2025
Figure 30. Americas TB Vaccines Sales 2020-2025 (K Units)
Figure 31. Americas TB Vaccines Revenue 2020-2025 ($ millions)
Figure 32. APAC TB Vaccines Sales 2020-2025 (K Units)
Figure 33. APAC TB Vaccines Revenue 2020-2025 ($ millions)
Figure 34. Europe TB Vaccines Sales 2020-2025 (K Units)
Figure 35. Europe TB Vaccines Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa TB Vaccines Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa TB Vaccines Revenue 2020-2025 ($ millions)
Figure 38. Americas TB Vaccines Sales Market Share by Country in 2025
Figure 39. Americas TB Vaccines Revenue Market Share by Country (2020-2025)
Figure 40. Americas TB Vaccines Sales Market Share by Type (2020-2025)
Figure 41. Americas TB Vaccines Sales Market Share by Application (2020-2025)
Figure 42. United States TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC TB Vaccines Sales Market Share by Region in 2025
Figure 47. APAC TB Vaccines Revenue Market Share by Region (2020-2025)
Figure 48. APAC TB Vaccines Sales Market Share by Type (2020-2025)
Figure 49. APAC TB Vaccines Sales Market Share by Application (2020-2025)
Figure 50. China TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. India TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe TB Vaccines Sales Market Share by Country in 2025
Figure 58. Europe TB Vaccines Revenue Market Share by Country (2020-2025)
Figure 59. Europe TB Vaccines Sales Market Share by Type (2020-2025)
Figure 60. Europe TB Vaccines Sales Market Share by Application (2020-2025)
Figure 61. Germany TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. France TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. UK TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa TB Vaccines Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa TB Vaccines Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa TB Vaccines Sales Market Share by Application (2020-2025)
Figure 69. Egypt TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of TB Vaccines in 2025
Figure 75. Manufacturing Process Analysis of TB Vaccines
Figure 76. Industry Chain Structure of TB Vaccines
Figure 77. Channels of Distribution
Figure 78. Global TB Vaccines Sales Market Forecast by Region (2026-2031)
Figure 79. Global TB Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global TB Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global TB Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global TB Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global TB Vaccines Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of TB Vaccines
Figure 2. TB Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global TB Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global TB Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. TB Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. TB Vaccines Sales Market Share by Country/Region (2024)
Figure 10. TB Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Immunotherapeutic Vaccines
Figure 12. Product Picture of Booster Vaccines
Figure 13. Product Picture of Others
Figure 14. Global TB Vaccines Sales Market Share by Type in 2025
Figure 15. Global TB Vaccines Revenue Market Share by Type (2020-2025)
Figure 16. TB Vaccines Consumed in Hospitals
Figure 17. Global TB Vaccines Market: Hospitals (2020-2025) & (K Units)
Figure 18. TB Vaccines Consumed in Private Clinics
Figure 19. Global TB Vaccines Market: Private Clinics (2020-2025) & (K Units)
Figure 20. TB Vaccines Consumed in Research Institutes
Figure 21. Global TB Vaccines Market: Research Institutes (2020-2025) & (K Units)
Figure 22. Global TB Vaccines Sale Market Share by Application (2024)
Figure 23. Global TB Vaccines Revenue Market Share by Application in 2025
Figure 24. TB Vaccines Sales by Company in 2025 (K Units)
Figure 25. Global TB Vaccines Sales Market Share by Company in 2025
Figure 26. TB Vaccines Revenue by Company in 2025 ($ millions)
Figure 27. Global TB Vaccines Revenue Market Share by Company in 2025
Figure 28. Global TB Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global TB Vaccines Revenue Market Share by Geographic Region in 2025
Figure 30. Americas TB Vaccines Sales 2020-2025 (K Units)
Figure 31. Americas TB Vaccines Revenue 2020-2025 ($ millions)
Figure 32. APAC TB Vaccines Sales 2020-2025 (K Units)
Figure 33. APAC TB Vaccines Revenue 2020-2025 ($ millions)
Figure 34. Europe TB Vaccines Sales 2020-2025 (K Units)
Figure 35. Europe TB Vaccines Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa TB Vaccines Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa TB Vaccines Revenue 2020-2025 ($ millions)
Figure 38. Americas TB Vaccines Sales Market Share by Country in 2025
Figure 39. Americas TB Vaccines Revenue Market Share by Country (2020-2025)
Figure 40. Americas TB Vaccines Sales Market Share by Type (2020-2025)
Figure 41. Americas TB Vaccines Sales Market Share by Application (2020-2025)
Figure 42. United States TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC TB Vaccines Sales Market Share by Region in 2025
Figure 47. APAC TB Vaccines Revenue Market Share by Region (2020-2025)
Figure 48. APAC TB Vaccines Sales Market Share by Type (2020-2025)
Figure 49. APAC TB Vaccines Sales Market Share by Application (2020-2025)
Figure 50. China TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. India TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe TB Vaccines Sales Market Share by Country in 2025
Figure 58. Europe TB Vaccines Revenue Market Share by Country (2020-2025)
Figure 59. Europe TB Vaccines Sales Market Share by Type (2020-2025)
Figure 60. Europe TB Vaccines Sales Market Share by Application (2020-2025)
Figure 61. Germany TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. France TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. UK TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa TB Vaccines Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa TB Vaccines Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa TB Vaccines Sales Market Share by Application (2020-2025)
Figure 69. Egypt TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries TB Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of TB Vaccines in 2025
Figure 75. Manufacturing Process Analysis of TB Vaccines
Figure 76. Industry Chain Structure of TB Vaccines
Figure 77. Channels of Distribution
Figure 78. Global TB Vaccines Sales Market Forecast by Region (2026-2031)
Figure 79. Global TB Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global TB Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global TB Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global TB Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global TB Vaccines Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Reprocessing Washer-disinfectors Market Growth 2023-2029
US$ 3,660.00
March 2023
99 pages
Global Biofeedback Instrument Market Growth 2025-2031
US$ 3,660.00
March 2025
119 pages
Global COVID-19 RT-PCR Detection Kits Market Growth 2023-2029
US$ 3,660.00
February 2023
101 pages
Global Microelectronic Medical Implants Market Growth 2025-2031
US$ 3,660.00
December 2024
114 pages
Global Medical Bathroom Seats Market Growth 2024-2030
US$ 3,660.00
March 2024
129 pages
